Opthea (OPT) News Today $3.89 +0.15 (+4.01%) As of 01/17/2025 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Opthea (NASDAQ:OPT) Shares Gap Up - What's Next?Opthea (NASDAQ:OPT) Shares Gap Up - Here's What HappenedJanuary 17 at 12:46 PM | marketbeat.comOpthea (NASDAQ:OPT) Trading 6.1% Higher - Here's What HappenedOpthea (NASDAQ:OPT) Shares Up 6.1% - Should You Buy?January 16 at 1:54 PM | marketbeat.comOpthea (NASDAQ:OPT) Trading Down 2.4% - Time to Sell?Opthea (NASDAQ:OPT) Trading Down 2.4% - Should You Sell?January 15 at 12:26 PM | marketbeat.comOpthea (NASDAQ:OPT) Sees Strong Trading Volume - Still a Buy?Opthea (NASDAQ:OPT) Sees Large Volume Increase - Time to Buy?January 14, 2025 | marketbeat.comOptimistic Buy Rating for Opthea Limited: Sozinibercept’s Promising Phase 3 Potential and Market PositioningJanuary 10, 2025 | markets.businessinsider.comOpthea to Host Investor Days in New York and AustraliaJanuary 8, 2025 | globenewswire.comOpthea to Host Investor Days Highlighting Sozinibercept’s Potential in Wet AMDJanuary 7, 2025 | tipranks.comOpthea (NASDAQ:OPT) Trading Up 1.6% - Here's What HappenedOpthea (NASDAQ:OPT) Stock Price Up 1.6% - Here's WhyJanuary 1, 2025 | marketbeat.comOpthea Limited Issues New Unquoted Equity SecuritiesDecember 23, 2024 | tipranks.comOpthea Limited Reports Cessation of SecuritiesDecember 23, 2024 | tipranks.comOpthea Limited Issues New Equity SecuritiesDecember 23, 2024 | tipranks.comOpthea Limited Issues New Shares on ASXDecember 23, 2024 | tipranks.comOpthea to Present Phase 3 Trial Update at J.P. Morgan Healthcare ConferenceDecember 20, 2024 | markets.businessinsider.comCanaccord Genuity Keeps Their Buy Rating on Opthea Limited (CKDXF)December 19, 2024 | markets.businessinsider.comOpthea to Present at 43rd Annual J.P. Morgan Healthcare ConferenceDecember 19, 2024 | globenewswire.comOpthea Limited Director Acquires Significant Stock OptionsDecember 17, 2024 | markets.businessinsider.comOpthea’s Director Increases Stake with New OptionsDecember 17, 2024 | markets.businessinsider.comOpthea Highlights Innovative Wet AMD TherapyNovember 26, 2024 | markets.businessinsider.comOpthea’s Wet AMD Program to be Featured at FLORetina 2024November 26, 2024 | markets.businessinsider.comOpthea's Wet AMD Program to be Featured at FLORetina 2024November 26, 2024 | globenewswire.comOpthea LimitedNovember 21, 2024 | afr.comOpthea Limited Targets AMD Market with SoziniberceptNovember 20, 2024 | markets.businessinsider.comOpthea Appoints Kathy Connell to Board of DirectorsNovember 15, 2024 | globenewswire.comOpthea Limited Appoints New Director with Stock OptionsNovember 15, 2024 | markets.businessinsider.comOpthea Limited Advances in Wet AMD TreatmentNovember 14, 2024 | tipranks.comOpthea Limited Strengthens Board Amidst Key Data PreparationsNovember 14, 2024 | tipranks.comOpthea’s Wet AMD Program Featured at Ophthalmology EventsNovember 12, 2024 | finance.yahoo.comOpthea to Highlight Promising AMD Therapy at Key EventsNovember 12, 2024 | markets.businessinsider.comOpthea (NASDAQ:OPT) Shares Up 1.7% - What's Next?Opthea (NASDAQ:OPT) Stock Price Up 1.7% - Time to Buy?November 9, 2024 | marketbeat.comOpthea Limited: Major Catalyst In Early 2025 For Complementary Eye Disease CandidateNovember 8, 2024 | seekingalpha.comOpthea to Participate in November Investor ConferencesNovember 5, 2024 | markets.businessinsider.comOpthea Limited to Present at Key November Investor ConferencesNovember 4, 2024 | markets.businessinsider.comOpthea Set to Highlight Innovations at Investor ConferencesNovember 3, 2024 | msn.comFY2025 EPS Estimates for Opthea Raised by Leerink PartnrsOpthea Limited (NASDAQ:OPT - Free Report) - Research analysts at Leerink Partnrs increased their FY2025 earnings per share (EPS) estimates for Opthea in a report issued on Tuesday, October 15th. Leerink Partnrs analyst M. Goodman now anticipates that the company will post earnings of ($1.15) perOctober 18, 2024 | marketbeat.comOpthea (NASDAQ:OPT) Stock Price Down 0.2% - Should You Sell?Opthea (NASDAQ:OPT) Stock Price Down 0.2% - Should You Sell?October 11, 2024 | marketbeat.comOpthea Wet AMD Program to be Presented at Innovate RetinaOctober 10, 2024 | globenewswire.comOpthea Appoints Chief Medical Officer and Chief Financial Officer as Company Prepares for Phase 3 Topline Data Readouts in 2025October 8, 2024 | finance.yahoo.comOpthea Hires Financial Chief Ahead of 2025 Trial ReadoutsOctober 8, 2024 | marketwatch.comOpthea to Participate in the UBS Virtual Ophthalmology Day 2024September 30, 2024 | globenewswire.comWhy Atlas Arteria, Coles, Healius, and Opthea shares are falling todaySeptember 24, 2024 | msn.comOpthea Joins the S&P/ASX 300 IndexSeptember 23, 2024 | markets.businessinsider.comWhy Lotus Resources, Opthea, Qoria, and Sims shares are charging higher todaySeptember 19, 2024 | msn.comOpthea Announces Completion of Drug Substance PPQ Campaign Validating Manufacturing Process of SoziniberceptSeptember 18, 2024 | globenewswire.comOpthea to Have Significant Presence at the 24?? EURETINA Congress and EURETINA Innovation SpotlightSeptember 10, 2024 | tmcnet.comOpthea to Have Significant Presence at the 24ᵗʰ EURETINA Congress and EURETINA Innovation SpotlightSeptember 10, 2024 | globenewswire.comFY2025 EPS Estimates for Opthea Limited (NASDAQ:OPT) Boosted by HC WainwrightOpthea Limited (NASDAQ:OPT - Free Report) - Research analysts at HC Wainwright boosted their FY2025 earnings estimates for Opthea in a note issued to investors on Tuesday, September 3rd. HC Wainwright analyst M. Caufield now forecasts that the company will post earnings of ($0.25) per share for tSeptember 6, 2024 | marketbeat.comOptimistic Buy Rating for Opthea Limited Amid Anticipated Success of Sozinibercept TrialsSeptember 5, 2024 | markets.businessinsider.comOpthea Limited (NASDAQ:OPT) to Post FY2029 Earnings of $0.50 Per Share, HC Wainwright ForecastsOpthea Limited (NASDAQ:OPT - Free Report) - Investment analysts at HC Wainwright issued their FY2029 earnings per share (EPS) estimates for Opthea in a note issued to investors on Tuesday, September 3rd. HC Wainwright analyst M. Caufield expects that the company will post earnings per share of $0September 5, 2024 | marketbeat.comOpthea Names Daniel Geffken CFO Ad Interim - Quick FactsSeptember 5, 2024 | markets.businessinsider.comOpthea Announces Executive Leadership Changes and Senior HiresSeptember 5, 2024 | globenewswire.com Get Opthea News Delivered to You Automatically Sign up to receive the latest news and ratings for OPT and its competitors with MarketBeat's FREE daily newsletter. Email Address OPT Media Mentions By Week OPT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPT News Sentiment▼0.800.46▲Average Medical News Sentiment OPT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPT Articles This Week▼41▲OPT Articles Average Week Get Opthea News Delivered to You Automatically Sign up to receive the latest news and ratings for OPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies COGT News PAHC News RLAY News CDMO News SANA News TYRA News SEPN News AVDL News IMTX News CRON News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OPT) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredDonald Trump is about to free crypto from its chains …With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Opthea Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Opthea With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.